Mike Binder Mike Binder

mRNA Technology Conference - Purilogics by Donaldson Presenting Jinxiang Zhou, April 22 2024 at 11:40am

In this presentation, Purilogics by Donaldson introduces the concept of using high-performance membrane chromatography technologies to rapidly purify SC pDNA and mRNA. We will illustrate purifying SC pDNA by capture chromatography using Purexa™ NAEX Plus, a weak anion chromatography membrane, followed by a polishing step using Purexa™ MCP, a hydrophobic interaction chromatography membrane that has superior and consistent capability to separate SC pDNA from open circular pDNA. We will illustrate purifying mRNA using Purexa™ OdT, an affinity capture chromatography membrane targeting the Poly A tails in mRNA.

Read More
Purexa™ NAEX, Purexa™ MCP, Purexa™ OdT jeremy hogenbaum Purexa™ NAEX, Purexa™ MCP, Purexa™ OdT jeremy hogenbaum

On Demand Webinar on mRNA Purification from Purilogics by Donaldson

Listen to company co-founder, Jin Zhou on how Purexa™ NAEX and MCP demonstrates fast and efficient purification of super coiled DNA, as well as how Purexa™ OdT shows superior performance in mRNA/IVT Purification. Purilogics products provide solutions and are tailored for high-throughput nucleic acid purification. Listen to this webinar to learn how to increase mRNA purification production with novel membrane chromatography.

Read More
Purexa™ PrA jeremy hogenbaum Purexa™ PrA jeremy hogenbaum

Purilogics to Present at Antibody Engineering & Therapeutics Conference

We’re excited to attend the Antibody Engineering & Therapeutics Conference in San Diego, CA from December 13th to 17th! Hosted by the Antibody Society, which is dedicated to the promotion of antibody research and development, this conference showcases the latest antibody technologies and science to accelerate next generation antibodies towards commercial success.

Read More
jeremy hogenbaum jeremy hogenbaum

Purilogics Awarded NIH Grant to Develop Novel Affinity Membranes for Enhanced mRNA Purification

Purilogics, a company recognized for its best-in-class membrane chromatography technology, development, and commercialization, is excited to announce that it has been awarded a significant grant from the National Institutes of Health (NIH) to support the research and development of first-in-market high-capacity, -selectivity, and -throughput affinity membranes for the purification of mRNA. With a grant amount of $1.7M from the Small Business Innovation Research (SBIR) program, Purilogics aims to develop mRNA affinity membranes with enabling accelerated purifications for both small and large mRNAs, as well as create and conduct field research on prototypes through industry collaboration.

Read More
jeremy hogenbaum jeremy hogenbaum

NIH Awards SBIR Grant to Purilogics to Develop Purexa™ Affinity Membrane to Improve mAb Purification Productivity

Purilogics, as a pioneer in novel high-performance membrane chromatography development, has received a second Small Business Innovation Research (SBIR) grant from National Institute of General Medical Sciences this year. This new award is a SBIR Phase II grant for ~$1.5 M to develop novel, Protein A based affinity chromatographic membranes with high binding capacities.

Read More
jeremy hogenbaum jeremy hogenbaum

Purilogics is Attending ACS Spring 2019

Purilogics is excited to attend ACS Spring 2019 in Orlando. We would love to talk shop about your purification challenges! Come visit us at our posters 6-8pm April 2nd to see the latest data on our multimodal anion exchange and Protein A membrane chromatography prototypes.

Read More